Imagine that
@damelisramty En ningún momento se justifica el antibiótico para neumonía por SARS-COV2, ni jala contra placebo 🙄, tiene tarea doc… https://t.co/ICvxZgpqIc
RT @FUNDAPROCECA: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection https://t.co/U1LEDz1…
RT @FUNDAPROCECA: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection https://t.co/U1LEDz1…
RT @FUNDAPROCECA: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection https://t.co/U1LEDz1…
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection https://t.co/U1LEDz1yZk vía @JAMA_current part of @JAMANetwork
"Among outpatients with SARS-CoV-2 infection, treatment with a single dose of azithromycin compared with placebo did not result in greater likelihood of being symptom free at day 14" https://t.co/Jaiazs8T4T
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms. Treatment with a single oral dose of azithromycin, 1.2 g, vs placebo resulted in self-reported absence of COVID-19 symptoms at day 14 in 50% vs 50% https://t.co/6Ol7gYzlPU via @JAMA_current par
Efecto de la azitromicina oral frente al placebo sobre los síntomas de COVID-19 en pacientes ambulatorios con infección por SARS-CoV-2 https://t.co/UxPzwCYeEd
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial #COVID19 @JAMA_current https://t.co/umvEad3w1u
RT @igormorr: Es igual que no dar nada ... Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infec…
RT @igormorr: Es igual que no dar nada ... Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infec…
Es igual que no dar nada ... Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection https://t.co/kB6LgRpYB3 vía @JAMA_current part of @JAMANetwork
RT @cragut: ¿Una sola dosis oral de azitromicina provoca la ausencia de síntomas el día 14 en pacientes ambulatorios con COVID-19 en compar…
Es nuestra sección “Parece una obviedad” hoy presentamos
RT @cragut: ¿Una sola dosis oral de azitromicina provoca la ausencia de síntomas el día 14 en pacientes ambulatorios con COVID-19 en compar…
¿Una sola dosis oral de azitromicina provoca la ausencia de síntomas el día 14 en pacientes ambulatorios con COVID-19 en comparación con placebo? Rta: NO👇 https://t.co/1VIy5mtXJn
RT @JAMA_current: Among outpatients with #SARSCoV2 infection, treatment with a single dose of oral #azithromycin compared with placebo did…
RT @giovannilandoni: By day 21, 5 participants in the #azithromycin group had been hospitalized compared with 0 in the placebo group (preva…
RT @HecmagsMD: Anyone else using azithromycin for patients with COVID-19? No better than placebo https://t.co/JUdVTDk5f0 https://t.co/HqEI…
RT @merlinoontheweb: Apperò come l'acqua fresca. #Covid19italia #ZeroCovid
Apperò come l'acqua fresca. #Covid19italia #ZeroCovid
RT @giovannilandoni: By day 21, 5 participants in the #azithromycin group had been hospitalized compared with 0 in the placebo group (preva…
By day 21, 5 participants in the #azithromycin group had been hospitalized compared with 0 in the placebo group (prevalence difference, 4%; 95% CI, −1% to 9%; P = .16). #rct #jama #covid19 #sarscov2 https://t.co/syH65JI8nm
RT @sergioassia: La azitromicina no sirve para tratar el #COVID19 La ivermectina tampoco (Cochrane dixit) no sobremediquen a los niños. h…
RT @sergioassia: La azitromicina no sirve para tratar el #COVID19 La ivermectina tampoco (Cochrane dixit) no sobremediquen a los niños. h…
RT @HecmagsMD: Anyone else using azithromycin for patients with COVID-19? No better than placebo https://t.co/JUdVTDk5f0 https://t.co/HqEI…
RT @sergioassia: La azitromicina no sirve para tratar el #COVID19 La ivermectina tampoco (Cochrane dixit) no sobremediquen a los niños. h…
RT @HecmagsMD: Anyone else using azithromycin for patients with COVID-19? No better than placebo https://t.co/JUdVTDk5f0 https://t.co/HqEI…
RT @sergioassia: La azitromicina no sirve para tratar el #COVID19 La ivermectina tampoco (Cochrane dixit) no sobremediquen a los niños. h…
RT @sergioassia: La azitromicina no sirve para tratar el #COVID19 La ivermectina tampoco (Cochrane dixit) no sobremediquen a los niños. h…
La azitromicina no sirve para tratar el #COVID19 La ivermectina tampoco (Cochrane dixit) no sobremediquen a los niños. https://t.co/S59uuUGOAd
RT @HecmagsMD: Anyone else using azithromycin for patients with COVID-19? No better than placebo https://t.co/JUdVTDk5f0 https://t.co/HqEI…
Anyone else using azithromycin for patients with COVID-19? No better than placebo https://t.co/JUdVTDk5f0 https://t.co/HqEIiy9Lnt
"Among outpatients with SARS-CoV-2 infection, treatment with a single dose of azithromycin compared with placebo did not result in greater likelihood of being symptom free at day 14" https://t.co/Jaiazs8T4T
Man wundert sich was alles untersucht wird, aber das Antibiotikum Azithromycin hilft auch nach einer Studie nicht gegen COVID19. https://t.co/8631ezXkZA
RT @BhavinBVasavada: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection https://t.co/qjO5…
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
Another study that doesn't show benefit in prescribing azithromycin in COVID19. Many colleagues in primary care from Cyprus and Greece continue to prescipe azithromycin routinely to their covid19 outpatients https://t.co/IkctMGnEvV
RT @JAMA_current: Among outpatients with #SARSCoV2 infection, treatment with a single dose of oral #azithromycin compared with placebo did…
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection https://t.co/1pVjxYKEyW via @JAMA_current part of @JAMANetwork "These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 in
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
RT @MasMadridSalud: (JAMA) 💊 Azitromicina no previene los síntomas en pacientes ambulatorios con infección por #SARS-Cov2. #antimicrobian…
RT @MasMadridSalud: (JAMA) 💊 Azitromicina no previene los síntomas en pacientes ambulatorios con infección por #SARS-Cov2. #antimicrobian…
RT @MasMadridSalud: (JAMA) 💊 Azitromicina no previene los síntomas en pacientes ambulatorios con infección por #SARS-Cov2. #antimicrobian…
(JAMA) 💊 Azitromicina no previene los síntomas en pacientes ambulatorios con infección por #SARS-Cov2. #antimicrobianos #PorMasSalud https://t.co/vVpjk8Ny3Z https://t.co/guu8vgiEHB
RT @JAMA_current: Among outpatients with #SARSCoV2 infection, treatment with a single dose of oral #azithromycin compared with placebo did…
RT @JAMA_current: Among outpatients with #SARSCoV2 infection, treatment with a single dose of oral #azithromycin compared with placebo did…
@Alicia So, giving azithromycin early to COVID-19 ambulatory patients does not shorten recovery time. No surprises. Did we really need to do this trial to show that antimicrobials do not effect a viral infection? But some folk were pushing Az last year. h
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
Azithromycine uniquement comme traitement : un traitement en vue ? Article publié …
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
N'importe quoi cette étude mais autorisée puis publiée quand même.... Bref...
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
RT @gkierzek: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seu…
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection. 263 patients et une seule dose d’azithromycine: posologie bizarre pour étude qui ne permet pas dire gd chose https://t.co/X18Nhef8OJ via @JAMA_current par
Doesn’t work here either. Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial | Infectious Diseases | JAMA | JAMA Network https://t.co/iV5djknaaS
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial https://t.co/cPJHexmG6C #covid19
Yet ANOTHER “covid cure” that was being pushed by politicians last year is shown to have no efficacy. Keep politics out of medicine. https://t.co/Xiw47IxT81
Effect of Z-pack vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection https://t.co/A2SApEqHOV via @JAMA_current part of @JAMANetwork
RT @FarmaMadridAP: (JAMA) Azitromicina no previene el desarrollo de síntomas en pacientes con infección por SARS-Cov2. EC frente a placebo…
Among outpatients with #SARS-CoV-2 infection, treatment with a single dose of #azithromycin compared with placebo did not result in greater likelihood of being symptom free at day 14 💊 Read more: https://t.co/jfVnmKLSNq
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial [July 16, 2021] Oldenburg et al. @JAMANetwork https://t.co/SvhBTMVtTe #NCT04332107 #COVID19
RT @FarmaMadridAP: (JAMA) Azitromicina no previene el desarrollo de síntomas en pacientes con infección por SARS-Cov2. EC frente a placebo…
RT @mdimairo: Trial results from an adaptive trial do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection. Real…
Trial results from an adaptive trial do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection. Really important study! #COVID19 https://t.co/QOZuqO0NL1
RT @rafabravo: Ni siquiera "por si acaso"
Is a single dose of azithromycin beneficial in COVID-19 outpatients? https://t.co/27rvp5zIdT Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/t3h9wtwwOQ
RT @FarmaMadridAP: (JAMA) Azitromicina no previene el desarrollo de síntomas en pacientes con infección por SARS-Cov2. EC frente a placebo…
RT @FarmaMadridAP: (JAMA) Azitromicina no previene el desarrollo de síntomas en pacientes con infección por SARS-Cov2. EC frente a placebo…
RT @gersonsalvador: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection A Randomized Clini…
RT @DrEmilyRSmith: New RCT from @CatieOldenburg and colleagues showing Azithromycin for outpatient COVID patients does not increase the lik…
💡Artigo publicado dia 16 de julho na JAMA. Leia o card para saber mais. Acesse o artigo completo no link https://t.co/RF3NY9eayJ #coronavirus #novocoronavirus #covid19 https://t.co/tTnJMh8slq
RT @FarmaMadridAP: (JAMA) Azitromicina no previene el desarrollo de síntomas en pacientes con infección por SARS-Cov2. EC frente a placebo…
In the lit from @JAMA_current: "Effect of oral azithromycin vs placebo on COVID-19 symptoms in outpatients with SARS-CoV-2 infection: a randomized clinical trial" (2/6) https://t.co/GbJazHnmL9
RT @GoogleMyrna: Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection https://t.co/Wy5d7a1V…
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection https://t.co/Wy5d7a1V7L via @JAMA_current part of @JAMANetwork
Effect of single dose Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection @JAMA_current https://t.co/zoyMAhuVGI
RT @rafabravo: Ni siquiera "por si acaso"
RT @jlunamd: ➡️Nuevo estudio, ahora de JAMA, que confirma que la Azitromicina NO funciona en COVID👇 ➡️16 de los 18 meses de pandemia dicién…
RT @jlunamd: ➡️Nuevo estudio, ahora de JAMA, que confirma que la Azitromicina NO funciona en COVID👇 ➡️16 de los 18 meses de pandemia dicién…
➡️Nuevo estudio, ahora de JAMA, que confirma que la Azitromicina NO funciona en COVID👇 ➡️16 de los 18 meses de pandemia diciéndolo y aún hay colegas recetandola ❌NO LA RECETE/NO LA USE❌ https://t.co/WtiC8ti48p https://t.co/gstVLHGm4n
RT @FarmaMadridAP: (JAMA) Azitromicina no previene el desarrollo de síntomas en pacientes con infección por SARS-Cov2. EC frente a placebo…
New RCT from @CatieOldenburg and colleagues showing Azithromycin for outpatient COVID patients does not increase the likelihood of symptom-free recovery after 2 weeks. More via @JAMA_current https://t.co/WTFqdeChUK https://t.co/5wXyhGaXYW
RT @FarmaMadridAP: (JAMA) Azitromicina no previene el desarrollo de síntomas en pacientes con infección por SARS-Cov2. EC frente a placebo…
RT @FarmaMadridAP: (JAMA) Azitromicina no previene el desarrollo de síntomas en pacientes con infección por SARS-Cov2. EC frente a placebo…
RT @rafabravo: Ni siquiera "por si acaso"
RT @rafabravo: Ni siquiera "por si acaso"
RT @rafabravo: Ni siquiera "por si acaso"
RT @JAMA_current: Among outpatients with #SARSCoV2 infection, treatment with a single dose of oral #azithromycin compared with placebo did…
RT @JAMA_current: Among outpatients with #SARSCoV2 infection, treatment with a single dose of oral #azithromycin compared with placebo did…